Literature DB >> 26454423

Comparison of commonly used antimicrobial susceptibility testing methods for evaluating susceptibilities of clinical isolates of Enterobacteriaceae and nonfermentative Gram-negative bacilli to cefoperazone-sulbactam.

Shio-Shin Jean1, Chun-Hsing Liao2, Wang-Huei Sheng3, Wen-Sen Lee4, Po-Ren Hsueh5.   

Abstract

BACKGROUND/
PURPOSE: The aim of this study was to investigate the cefoperazone-sulbactam (CFP-SUL) susceptibilities of important Gram-negative bacteria (GNB) by agar dilution (reference method), disk diffusion, and two automated methods.
METHODS: A total of 799 GNB isolates, including Enterobacteriaceae (n = 500) and nonfermentative GNB (NFGNB, n = 299), were recovered from various clinical specimens collected at National Taiwan University Hospital, Taipei, Taiwan from November 2013 to December 2014. The agar dilution method, disk diffusion method, and two automated susceptibility systems (Phoenix and Vitek 2) were used for testing susceptibility of the isolates to CFP-SUL. Categories of susceptibility (susceptible, intermediate, or resistant) to CFP-SUL yielded from each method were interpreted according to CFP-SUL interpretive breakpoints proposed previously. The results of categorical agreement and errors obtained between the agar dilution method and the other three methods were analyzed.
RESULTS: The Vitek 2 system had the highest error rates against Escherichia coli (n = 150) and Enterobacter cloacae (n = 77) isolates, i.e., 6.7% and 11.7% minor errors, 8.5% and 1.7% major errors, and 40% and 20% very major errors, respectively. Additionally, the Vitek 2 system was also found to have a significantly lower sensitivity (44.4%) and lower positive predictive value (18.2%) for detecting CFP-SUL nonsusceptible E. coli isolates than other methods. For carbapenem-nonsusceptible Enterobacteriaceae isolates, the Vitek 2 system failed to detect correct susceptibility to CFP-SUL. The three methods failed to correctly detect CFP-SUL susceptibility categories against all NFGNB isolates except Pseudomonas aeruginosa.
CONCLUSION: The Vitek 2 system is a suboptimal method in correctly detecting CFP-SUL susceptibility categories for E. coli, E. cloacae, and carbapenem-nonsusceptible Enterobacteriaceae isolates.
Copyright © 2015. Published by Elsevier B.V.

Entities:  

Keywords:  Vitek 2 system; cefoperazone–sulbactam; disk diffusion; phoenix system; susceptibility test

Mesh:

Substances:

Year:  2015        PMID: 26454423     DOI: 10.1016/j.jmii.2015.08.024

Source DB:  PubMed          Journal:  J Microbiol Immunol Infect        ISSN: 1684-1182            Impact factor:   4.399


  8 in total

1.  One Day in Denmark: Comparison of Phenotypic and Genotypic Antimicrobial Susceptibility Testing in Bacterial Isolates From Clinical Settings.

Authors:  Ana Rita Rebelo; Valeria Bortolaia; Pimlapas Leekitcharoenphon; Dennis Schrøder Hansen; Hans Linde Nielsen; Svend Ellermann-Eriksen; Michael Kemp; Bent Løwe Røder; Niels Frimodt-Møller; Turid Snekloth Søndergaard; John Eugenio Coia; Claus Østergaard; Henrik Westh; Frank M Aarestrup
Journal:  Front Microbiol       Date:  2022-06-10       Impact factor: 6.064

2.  Optimal Dose of Cefoperazone-Sulbactam for Acute Bacterial Infection in Patients with Chronic Kidney Disease.

Authors:  Chien-Ming Chao; Chih-Cheng Lai; Chen-Hsiang Lee; Hung-Jen Tang
Journal:  Antibiotics (Basel)       Date:  2022-04-30

3.  Clinical Outcomes and Adverse Effects in Septic Patients with Impaired Renal Function Who Received Different Dosages of Cefoperazone-Sulbactam.

Authors:  Chien-Hsiang Tai; Hung-Jen Tang; Chen-Hsiang Lee
Journal:  Antibiotics (Basel)       Date:  2022-03-29

4.  Integrating Bacterial Identification and Susceptibility Testing: A Simple and Rapid Approach to Reduce the Turnaround Time in the Management of Blood Cultures.

Authors:  Dariane C Pereira; Luciano Z Goldani
Journal:  Biomed Res Int       Date:  2019-10-03       Impact factor: 3.411

5.  Diagnostic evaluation of a point-of-care test for culture and microbial susceptibility testing in canine dermatological infections in clinical practice.

Authors:  Roberta Perego; Eva Spada; Piera Anna Martino; Daniela Proverbio
Journal:  Vet World       Date:  2020-03-20

6.  Development of an In-House Rapid Antimicrobial Susceptibility Testing Protocol for Positive Blood Culture and Its Implementation in Routine Microbiology Laboratories.

Authors:  Min Cao; Lin Huang; Yanyan Hu; Yinfei Fang; Rong Zhang; Gongxiang Chen
Journal:  Front Microbiol       Date:  2021-11-30       Impact factor: 5.640

7.  Evaluation of antibiotic susceptibility test results: how guilty a laboratory could be?

Authors:  Mohamed S M Nassar; Walaa A Hazzah; Wafaa M K Bakr
Journal:  J Egypt Public Health Assoc       Date:  2019-01-11

8.  Clinical Efficacy of Cefoperazone-Sulbactam versus Piperacillin-Tazobactam in the Treatment of Hospital-Acquired Pneumonia and Ventilator-Associated Pneumonia.

Authors:  Chia-Hung Chen; Chih-Yen Tu; Wei-Chih Chen; Li-Kuo Kuo; Yao-Tung Wang; Pin-Kuei Fu; Shih-Chi Ku; Wen-Feng Fang; Chin-Ming Chen; Chih-Cheng Lai
Journal:  Infect Drug Resist       Date:  2021-06-16       Impact factor: 4.003

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.